PillsCard
Reading from 50+ regulators…
Loading the latest data0%
PillsCard
Reading from 50+ regulators…
See teave on mõeldud ainult hariduslikel eesmärkidel. See ei ole meditsiiniline nõuanne. Konsulteerige alati kvalifitseeritud tervishoiutöötajaga.
Kirjeldus, Annustamine, Kõrvaltoimed, Vastunäidustused. Data from EMA, URPL, openFDA and other regulatory sources.
| Ramipril | Lisinopril | |
|---|---|---|
| Toimeained | RAMIPRIL | LISINOPRIL |
| ATC kood | C09AA05 | C09AA03 |
| Ravimvorm | — | TABLET |
| Annustamine | — | 40 mg/1 |
| Manustamisviis | — | ORAL |
| Tootja | ANGITA PHARMA INC. | NuCare Pharmaceuticals, Inc. |
Ramipril (INN: RAMIPRIL, ATC C09AA05) and Lisinopril (INN: LISINOPRIL, ATC C09AA03) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
See teave on mõeldud ainult hariduslikel eesmärkidel. See ei ole meditsiiniline nõuanne. Konsulteerige alati kvalifitseeritud tervishoiutöötajaga.